Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 700716, 2021.
Article
in En
| MEDLINE
| ID: mdl-34054884
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
México
Country of publication:
Suiza